Notice ID: 889d74550860440aa802f9f72c77474eCombined Synopsis/Solicitation
Biological Therapeutics Product Development Subject Matter Expert Consulting Services to Support the Development of Therapeutic Biotechnology Products (Biologics)
Archived on November 27, 2021. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 6:00 PM UTC−05:00
- Posted
- November 10, 2021
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Small Business Set Aside - Total
- NAICS
- 541690: Other Scientific and Technical Consulting Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 25, 2026
Identifiers
- Solicitation number
- NIH-NINDS-CSS-22-000015
- Notice ID
- 889d74550860440aa802f9f72c77474e
Description
Amendment 2: Two questions and answers added to Q&A document; two-page limit removed for Key Personnel Narrative, and minor adjustment made to Information/Physical Access Security document. Amendment 1: Consolidated Q&A document posted in response to questions submitted by 11/5 deadline. Revised documents also posted for Combined Synopsis/Solicitation (pgs 3-4), Statement of Work (pgs 9-10), Tech Eval Criteria (pgs 4-5), and Information/Physical Access Security (pgs 8-12). Description: The National Institute of Neurological Disorders and Stroke (NINDS) has a need for biological therapeutics development subject matter expert (SME) consulting services. SME consultants will be required to provide technical recommendations and advice that will support the translational development of novel therapeutics (Biologics) for NIH drug discovery and development programs. Several such programs are being launched or expanded to provide support for investigators developing medical interventions for neurological disorders. These include the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics) program, the NINDS Ultra-Rare Gene Therapy (URGenT) program, the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP), and other extramural or intramural NIH programs. The SMEs will support these biologics development programs by providing consulting services related to candidate biologics therapeutics development, current Good Manufacturing Practices (cGMP) manufacturing, and evaluation of the biologics in Phase 1 clinical trials. Please review the attachments for additional information.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
Solicitation:
NIH-NINDS-CSS-22-000015- Combined Synopsis
- 3×Combined SynopsisCurrentOct 29, 2021
Biological Therapeutics Product Development Subject Matter Expert Consulting Services to Support the Development of Therapeutic Biotechnology Products (Biologics)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
NIH-NINDS-CSS-22-000015
Archive Date
Nov 27, 2021
Office Address
Bethesda, MD, 20892